GlassScriptPhysician profile
Haisar E Dao Campi
NPI 1144493891
$6,409.64
in general payments reported to CMS, 2019-2025
14 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $269 · 2021: $199 · 2022: $4,380 · 2023: $589 · 2024: $257 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,318.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,806.82 | 2019-2025 | Da Vinci Surgical System |
| Imbed Biosciences INC. | $522.06 | 2023 | |
| Boston Scientific Corporation | $387.49 | 2025 | Axonics |
| Covidien LP | $260.14 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Mimedx Group, INC. | $114.70 | 2024 | |
| Acell, INC. | $36.67 | 2019 | |
| Medtronic, INC. | $26.31 | 2022 | |
| Janssen Scientific Affairs, LLC | $25.70 | 2023 | Stelara |
| Pacira Pharmaceuticals Incorporated | $22.47 | 2025 | Exparel |
| Heron Therapeutics, INC. | $22.15 | 2023 | Zynrelef |
| Integra Lifesciences Corporation | $21.38 | 2021 | |
| Conmed Corporation | $21.05 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.70 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haisar Dao Campi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.